Video

Should Men with Prior CVD be Treated Preferentially with a GnRH Antagonist?

Dr Higano provides a timeline review of safety results for GnH agonists and GnRH antagonists including the recent prospective phase 3 PRONOUNCE study for prostate cancer patients with pre-existing CV disease, followed by closing thoughts on this video series.

Video Player is loading.
Current Time 0:00
Duration 12:13
Loaded: 1.36%
Stream Type LIVE
Remaining Time 12:13
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    January 2023 AbbVie Inc. Company Confidential

    © 2025 MJH Life Sciences

    All rights reserved.